Despite extending the dispute-and-resolution deadline to account for the days that the Centers for Medicare & Medicaid Services (CMS) pulled down the reporting system, the public Physician Payments Sunshine Act website is still expected to go live in a matter
FDA’s expanded oversight of “high-risk” diagnostic devices
In efforts to ensure that in vitro diagnostic devices1 provide accurate, consistent and reliable results, the US Food and Drug Administration (“FDA” or “the Agency”) 1) issued a final guidance on the development, review and approval or clearance of
Comparing the United States and Canadian Experience
Published in: For The Defense
Products regulated in the United States by the U.S. Food and Drug Administration (FDA) and in Canada by Health Canada are subject to a complex set of regulatory requirements. These regulatory requirements will often include
China healthcare reforms: Foreign-owned hospitals to be established in 7 cities and provinces
This is a major breakthrough for healthcare services in China and is a particularly welcome development